{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:04:13Z","timestamp":1785787453794,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.vaccine.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T07:06:21Z","timestamp":1675753581000},"page":"1892-1901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants"],"prefix":"10.1016","volume":"41","author":[{"given":"Hye Won","family":"Kwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1601-7638","authenticated-orcid":false,"given":"Hyo-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo-Yeon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8662-1999","authenticated-orcid":false,"given":"Sang-In","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonhwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Li","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeran","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ho","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Eun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhyuk","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ouk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manki","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jeen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Weon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunse","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dokeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-7094","authenticated-orcid":false,"given":"Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-3392","authenticated-orcid":false,"given":"Sang-Myeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hwan","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.02.005_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2023.02.005_b0010","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg3055","article-title":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England","author":"Davies","year":"20213723055","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.02.005_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104869","article-title":"One year into the pandemic: short-term evolution of SARS-CoV-2 and emergence of new lineages","volume":"92","author":"Gonzalez-Candelas","year":"2021","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2023.02.005_b0020","doi-asserted-by":"crossref","unstructured":"Sean Wei Xiang Ong TC, Young BE. SARS-CoV-2 variants of concern and vaccine escape, from Alpha to Omicron and beyond. Expert Rev Respir Med. 2022;16(5):499-502. 10.1080\/17476348.2022.2057299.","DOI":"10.1080\/17476348.2022.2057299"},{"key":"10.1016\/j.vaccine.2023.02.005_b0025","unstructured":"https:\/\/covid19.trackvaccines.org\/; 2022 [accessed 2020]."},{"key":"10.1016\/j.vaccine.2023.02.005_b0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.micinf.2018.01.005","article-title":"Measles-derived vaccines to prevent emerging viral diseases","volume":"20","author":"Frantz","year":"2018","journal-title":"Microbes Infect"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2023.02.005_b0035","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1086\/368032","article-title":"Progress toward measles eradication in the region of the Americas","volume":"187","author":"De Quadros","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.02.005_b0040","first-page":"411","article-title":"Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine","volume":"10","author":"Ovsyannikova","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2023.02.005_b0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1574-6976.2012.00330.x","article-title":"Measles virus, immune control, and persistence","volume":"36","author":"Griffin","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2023.02.005_b0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/vim.2005.18.317","article-title":"Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector","volume":"18","author":"Tangy","year":"2005","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2023.02.005_b0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.02.005_b0060","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/S0140-6736(18)32488-7","article-title":"Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial","volume":"392","author":"Reisinger","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.02.005_b0065","article-title":"Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot","author":"Mateo","year":"2019113163","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2023.02.005_b0070","doi-asserted-by":"crossref","first-page":"e01485","DOI":"10.1128\/JVI.01485-18","article-title":"A measles virus-based vaccine candidate mediates protection against Zika virus in an allogeneic mouse pregnancy model","volume":"93","author":"Nurnberger","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.02.005_b0075","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.vaccine.2023.02.005_b0080","doi-asserted-by":"crossref","first-page":"9238696","DOI":"10.1155\/2020\/9238696","article-title":"SARS-CoV-2, early entry events","volume":"2020","author":"Chambers","year":"2020","journal-title":"J Pathog"},{"key":"10.1016\/j.vaccine.2023.02.005_b0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2023.02.005_b0090","doi-asserted-by":"crossref","first-page":"32657","DOI":"10.1073\/pnas.2014468117","article-title":"A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine","volume":"117","author":"Horner","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2023.02.005_b0095","doi-asserted-by":"crossref","unstructured":"Lu M, Dravid P, Zhang Y, Trivedi S, Li A, Harder O, et al. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike. Proc Natl Acad Sci U S A. 2021;118:e2026153118. 10.1073\/pnas.2026153118.","DOI":"10.1073\/pnas.2026153118"},{"key":"10.1016\/j.vaccine.2023.02.005_b0100","article-title":"Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates","author":"Hong","year":"202177156","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2023.02.005_b0105","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1128\/JVI.73.5.3560-3566.1999","article-title":"Enhanced measles virus cDNA rescue and gene expression after heat shock","volume":"73","author":"Parks","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.02.005_b0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","volume":"169","author":"Whitt","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2023.02.005_b0115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/clinchem\/hvaa029","article-title":"Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia","volume":"66","author":"Chu","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.vaccine.2023.02.005_b0120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/viro.1998.9301","article-title":"Role of CD46 in measles virus infection in CD46 transgenic mice","volume":"249","author":"Blixenkrone-Moller","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2023.02.005_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.732450","article-title":"Peptides derived from S and N proteins of severe acute respiratory syndrome coronavirus 2 induce T cell responses: a proof of concept for T cell vaccines","volume":"12","author":"Lee","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2023.02.005_b0130","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.02.005_b0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13567-021-00988-w","article-title":"Ultra- and micro-structural changes of respiratory tracts in SARS-CoV-2 infected Syrian hamsters","volume":"52","author":"Yang","year":"2021","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2023.02.005_b0140","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41467-021-21665-8","article-title":"Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques","volume":"12","author":"Tan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.02.005_b0145","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2023.02.005_b0150","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.02.005_b0155","doi-asserted-by":"crossref","unstructured":"Laing AG, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26:1623-35. 10.1038\/s41591-020-1038-6.","DOI":"10.1038\/s41591-020-1038-6"},{"key":"10.1016\/j.vaccine.2023.02.005_b0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13054-021-03662-x","article-title":"Emerging SARS-CoV-2 variants of concern and potential intervention approaches","volume":"25","author":"Khateeb","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.vaccine.2023.02.005_b0165","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41591-022-01715-4","article-title":"Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern","volume":"28","author":"Wratil","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.02.005_b0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41541-022-00597-4","article-title":"Challenges and developments in universal vaccine design against SARS-CoV-2 variants","volume":"7","author":"Zhao","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2023.02.005_b0175","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees","author":"Geers","year":"202161750","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2023.02.005_b0180","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.005_b0185","article-title":"Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?","volume":"8","author":"Das","year":"2021","journal-title":"Children (Basel)"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2023.10.033","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T01:21:07Z","timestamp":1709688067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0264410X23001317"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.005","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.vaccine.2023.10.033","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}